medical device engineering

Advanced Vascular Therapies (AVT) is a seed stage company founded by sister-brother team Kat and Kerry Logan to help people with poor circulation retain their independence through non-invasive therapeutic options. AVT is developing a novel pneumatic compression device (PCD) designed to heal non-healing ulcers and prevent amputation. The company is a Purdue University Foundry client and is currently in the prototyping stage, with FDA approval expected in 2027.

product developmentprototyping

Cern Corporation is a women's health medical device company developing a prescription, non-drug platform that uses controlled, low-level visible-spectrum (non-UV) microbicidal light to treat both yeast and bacterial vaginal infections. The CernDevice is designed to work with a proprietary photosensitizing, lubricating gel. The technology is in IRB-approved human clinical evaluation and is not FDA-cleared or approved.

clinical evaluationmicrobicidal light-based medical device developmentmicrobiology research

Extremity Medical develops novel technologies that enhance the mechanical properties of medical devices for extremity orthopedic procedures. Founded in 2008 by Matt Lyons, the company specializes in next-generation products for fusion, fixation, and motion preservation systems tailored for the upper and lower extremities, and is located in Parsippany, NJ.

in-house cadaver labproduct developmentQuality ManagementRegulatory Affairssurgeon training

Haystack Medical is developing minimally invasive inner ear access and drug delivery technologies. Its ultra-sharp needles push apart the connective fibers of the round window membrane to provide access to the inner ear, aimed at precision delivery and diagnostics for inner ear therapies. The team includes clinicians, engineers, and scientists, and reports 20+ publications on microneedle-mediated inner ear access.

microneedle-based inner ear drug deliveryminimally invasive inner ear access

Insulet (NASDAQ: PODD) is a medical device company headquartered in Acton, Massachusetts, that developed Omnipod, a line of tubeless, wearable, Pod-based insulin management systems. Founded in 2000 by a father determined to free his son from multiple daily insulin injections, the company provides continuous insulin delivery through a wearable, tubeless, waterproof insulin pump called a Pod. Insulet products are available in 26 countries.

clinical trialsmanufacturingproduct designresearch and development